For use with travelers who might have been exposed to patients with Ebola and are sick with symptoms consistent with Ebola infection and require further evaluation
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...d with the Ebola virus:
BCX4430 (Biocryst);
Brincidofovir (Chimerix);
Favipiravir (Fujifilm Corporation/Toyama);
TKM-100802 (Tekmira);
AVI-7537 (Sarepta);
ZMapp (Leafbio Inc.);
Anti-Ebola F(ab’)2 (Fab’entech).
The amount of information available for the seven treatments is highly variable. For some compounds there is no data from use in human subjects available. A small number of treatments have been administered to patients in the current Ebola outbreak as compassionate use. Finally, there are also medicines included in this review that have already been studied in humans, albeit for the treatment of other viral diseases.
more
The interventions summarized in this guide are intended to lower the risk of delivery and post-partum complications for both the mother and the newborn, particularly the risk of postpartum haemorrhage and infections, and improve the immediate care of premature babies. The recommendations are also in...tended to minimize the exposure of health care providersto blood and bodily fluids that could transmit Ebola
more
Please read online the lastest updated versions http://www.cdc.gov/vhf/ebola/qa.html
Progress in diagnosis: Akey in overcoming the MDR-TB crisis.
The expanse-TV project progress and impact brief.
CAFOD Policy Briefing Paper
In 2014 UNICEF, WHO and the World Bank report new joint estimates of child malnutrition using available data up to 2013 The Interactive dashboard allows users to generate a variety of graphs and charts, using the newest joint estimates of prevalence and numbers for child stunting, underweight, overw...eight, wasting and severe wasting. Users can select the different regional country groupings of the UN, MDG, UNICEF, WHO regions as well as World Bank income groups and geographic regions to present the data.
A summary of 4 pages presents the key findings for each indicator, an introduction to the dashboard and updates on methods
more